Back to Search
Start Over
Alterations in endothelin type B receptor contribute to microvascular dysfunction in women who have had preeclampsia.
- Source :
-
Clinical science (London, England : 1979) [Clin Sci (Lond)] 2017 Nov 23; Vol. 131 (23), pp. 2777-2789. Date of Electronic Publication: 2017 Nov 23 (Print Publication: 2017). - Publication Year :
- 2017
-
Abstract
- Microvascular dysfunction originating during a preeclamptic pregnancy persists postpartum and probably contributes to increased CVD risk in these women. One putative mechanism contributing to this dysfunction is increased vasoconstrictor sensitivity to endothelin-1 (ET-1), mediated by alterations in ET-1 receptor type-B (ET <subscript>B</subscript> R). We evaluated ET-1 sensitivity, ET <subscript>A</subscript> R, and ET <subscript>B</subscript> R contributions to ET-1-mediated constriction, and the mechanistic role of ET <subscript>B</subscript> R in endothelium-dependent dilation in vivo in the microvasculature of postpartum women who had preeclampsia (PrEC, n =12) and control women who had a healthy pregnancy (HC, n =12). We hypothesized that (1) PrEC would have a greater vasoconstrictor response to ET-1, and (2) reduced ET <subscript>B</subscript> R-mediated dilation. We further hypothesized that ET <subscript>B</subscript> R-blockade would attenuate endothelium-dependent vasodilation in HC, but not PrEC. Microvascular reactivity was assessed by measurement of cutaneous vascular conductance responses to graded infusion of ET-1 (10 <superscript>-20</superscript> -10 <superscript>-8</superscript> mol/l), ET-1 + 500 nmol/l BQ-123 (ET <subscript>A</subscript> R-blockade), and ET-1 + 300 nmol/l BQ-788 (ET <subscript>B</subscript> R-blockade), and during graded infusion of acetylcholine (ACh, 10 <superscript>-7</superscript> -10 <superscript>2</superscript> mmol/l) and a standardized local heating protocol with and without ET <subscript>B</subscript> R-inhibition. PrEC had an increased vasoconstriction response to ET-1 ( P =0.02). PrEC demonstrated reduced dilation responses to selective ET <subscript>B</subscript> R stimulation with ET-1 ( P =0.01). ET <subscript>B</subscript> R-inhibition augmented ET-1-mediated constriction in HC ( P =0.01) but attenuated ET-1-mediated constriction in PrEC ( P =0.003). ET <subscript>B</subscript> R-inhibition attenuated endothelium-dependent vasodilation responses to 100mmol/l ACh ( P =0.04) and local heat ( P =0.003) in HC but increased vasodilation (ACh: P =0.01; local heat: P =0.03) in PrEC. Women who have had preeclampsia demonstrate augmented vasoconstrictor sensitivity to ET-1, mediated by altered ET <subscript>B</subscript> R signaling. Furthermore, altered ET <subscript>B</subscript> R function contributes to diminished endothelium-dependent dilation in previously preeclamptic women.<br /> (© 2017 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.)
- Subjects :
- Acetylcholine pharmacology
Adult
Biopsy
Endothelin-1 pharmacology
Endothelium, Vascular drug effects
Endothelium, Vascular pathology
Endothelium, Vascular physiopathology
Female
Galvanic Skin Response
Humans
Microdialysis
Nitric Oxide pharmacology
Norepinephrine pharmacology
Pregnancy
Receptor, Endothelin A
Signal Transduction drug effects
Skin pathology
Vasoconstriction drug effects
Vasodilation drug effects
Young Adult
Microvessels metabolism
Microvessels physiopathology
Pre-Eclampsia metabolism
Pre-Eclampsia physiopathology
Receptor, Endothelin B metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1470-8736
- Volume :
- 131
- Issue :
- 23
- Database :
- MEDLINE
- Journal :
- Clinical science (London, England : 1979)
- Publication Type :
- Academic Journal
- Accession number :
- 29042489
- Full Text :
- https://doi.org/10.1042/CS20171292